Perspective: The consequence of secret prices: The politics of physician preference items

Health Affairs

Volumn 27, Issue 6, 2008, Pages 1560-1565

  Lerner, Jeffrey C ^a   Fox, Daniel M ^b   Nelson, Todd ^c   Reiss, John B ^d  

^a ECRI INSTITUTE   (United States)

^b Milbank Memorial Fund   (United States)

^c Grinnell Regional Medical Center   (United States)

^d Saul Ewing LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR EQUIPMENT; CONFIDENTIALITY; DEVICE; HEALTH CARE COST; HIP PROSTHESIS; HOSPITAL PURCHASING; IMPLANT; KNEE PROSTHESIS; MEDICAID; MEDICAL INSTRUMENTATION; MEDICARE; PHYSICIAN; PHYSICIAN PREFERENCE ITEM; REVIEW; SURGEON; ARTICLE; COMMERCIAL PHENOMENA; CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH SERVICES RESEARCH; HEART MUSCLE REVASCULARIZATION; MEDICAL TECHNOLOGY; PROSTHESES AND ORTHOSES; QUALITY ADJUSTED LIFE YEAR;

COMMERCE; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; MYOCARDIAL REVASCULARIZATION; ORGANIZATIONAL CASE STUDIES; PHYSICIANS; PROSTHESES AND IMPLANTS; QUALITY-ADJUSTED LIFE YEARS; TECHNOLOGY, MEDICAL;

EID: 56649118869     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.6.1560     Document Type: Review

References (36)

1. Office of Sen. Chuck Grassley, "Grassley, Specter Introduce Transparency in Medical Device Pricing Act" (Washington: Office of Sen. Chuck Grassley, 23 October 2007).
2. M.V. Pauly and L.R. Burns, "Price Transparency for Medical Devices," Health Affairs 27, no. 6 (2008): 1544-1553.
3. Regarding the cost of medical devices, see Office of Sen. Arlen Specter, "Arlen Specter Speaks on the Senate Floor regarding the Transparency in Medical Devices Act" (Washington: Office of Sen. Arlen Specter, 23 October 2007);
4. and R. King and G.F. Donahoe, "Estimates of Medical Device Spending in the United States," http://www.advamed.org/NR/rdonlyres/C3DEC303-E7C8- 4E44-B1FE-5DD3E06573A4/0/KingpaperMedicalDeviceSpending21308FINAL.pdf (accessed 9 May 2008).
5. Regarding returns to shareholders, see "The Bleeding Edge: The Drugs Giants Are in Trouble, but Medical Devices Are Booming," Economist (1-7 March 2008): 66-67.
6. Office of Sen. Grassley, "Grassley, Specter Introduce Transparency in Medical Device Pricing Act."
7. Raymond J. Siegfried, senior vice president, Christiana Care Health System (Newark, Del.), letter to Timothy B. Strachan, counsel, Senate Committee on the Judiciary, May 2007.
8. Todd Nelson, vice president and CFO, Grinnell (Iowa) Regional Medical Center, letter to Strachan, 25 May 2007.
9. Emergency Care Research Inst. v. Guidant Corp., 2007 U.S. Dist. LEXIS 67658 (E.D. Pa. Sept. 12, 2007);
10. and Cardiac Pacemakers, Inc. v. Aspen II Holding Co., 413 F. Supp. 2d 1016 (2006).
11. A. Bridy, "Trade Secret Prices and High-Tech Devices: How Medical Device Manufacturers Are Seeking to Sustain Profits by Propertizing Prices," Texas Intellectual Property Law Journal (forthcoming).
12. R.W. Hahn and H.J. Singer, "Is Greater Price Transparency Needed in the Medical Device Industry?" 2007, http://www.criterioneconomics.com/docs/ Hahn_Singer_Disclosure_final_12-7.pdf (accessed 19 August 2008).
13. D.A. Austin and J.G. Gravelle, Does Price Transparency Improve Market Efficiency? Implications of Empirical Evidence in Other Markets of the Health Sector, Congressional Research Service Report for Congress, Order Code RL34101 (Washington: CRS, updated 29 April 2008).
14. New York State Office of General Services, Procurement Services Group, "Purchasing Memorandum: Contract Award Notification Update," http://www.ogs.state.ny.us/purchase/spg/pdfdocs/1260102612a.pdf (accessed 9May 2008).
15. E. McGinnity, "Will One Small Step Lead to One Giant Economic Leap?" Healthcare Publishing News Online, December 2006, http://www.hpnonline.com/inside/2006-12/0612-CBS.html (accessed 13 May 2008); and Cardiac Pacemakers, Inc. v. Aspen II Holding Co.
16. B.M. Nudell, "BMET, SYK, and ZMH: Price Transparency Is a Major Threat. Downgrading BMET; Lower ZMH Target to $62 and SYK to $44" (New York: Sanford C. Bernstein and Co., 2006).
17. ECRI Institute, PriceGuide (proprietary database online).
18. Nudell, "BMET, SYK, and ZMH."
19. J. Robinson, "Value Assessment and Purchasing for Medical Devices: The California Perspective" (Lecture, IHA-CHA Medical Device Conference, San Francisco, California, 22 May 2008).
20. Ibid.
21. U.S. Senate, "Statements on Introduced Bills and Joint Resolutions," Sec. 29, 23 October 2007, "S. 2221: Transparency in Medical Device Pricing Act of 2007," http://www.govtrack.us/congress/ record.xpd?id=110-s20071023-29&person=300048 (accessed 18 September 2008).
22. American Hospital Association, "Hospital Pricing Transparency," 29 April 2006, http://www.aha.org/aha/content/2006/pdf/5_1_06_sb_transparency. pdf (accessed 9 May 2008).
23. Attorney General Consumer and Prescriber Education Grant Program, "The Marketing of Medicines: Development, Dissemination, and Evaluation of a Critical Skills Curriculum for Prescribers," Request for Applications, 31 August 2005, http://www.doj.state.or.us/releases/pdf/rfa.pdf (accessed 28 July 2008).
24. Peter V. Lee, chief executive officer, Pacific Business Group on Health, letter to Sen. Arlen Specter, 14 September 2007.
25. Debra L. Ness, National Partnership for Women and Families, letter to Sen. Arlen Specter, 22 August 2007.
26. Steve Phurrough, director, Coverage and Analysis Group, CMS Office of Clinical Standards and Quality, personal communication (J. Lerner), 24 April 2008;
27. and Morgan Stanley Equity Research, "ICD Costs: U.S. and Worldwide," Market Analysis Table (New York: Morgan Stanley, 2007).
28. D. Goldman et al., "Modeling the Health and Medical Care Spending of the Future Elderly," RAND Health Research Highlights, 2008, http://rand.org/pubs/research_briefs/2008/RAND_RB9324.pdf (accessed 1 May 2008).
29. Congressional Budget Office, "Technological Change and the Growth of Health Care Spending," January 2008, http://www.cbo.gov/ftpdocs/89xx/ doc8947/01-31-TechHealth.pdf (accessed 15 May 2008);
30. and Peter Orszag, director, Congressional Budget Office, personal communication, 23 April 2008.
31. Phurrough, personal communication.
32. Ibid.
33. ECRI Institute, PriceGuide.
34. R.I. Field, "Regulation of Health Care Business Relationships," in Health Care Regulation in America: Complexity, Confrontation, and Compromise (Oxford, England: Oxford University Press, 2007), chap. 7, 173-204.
35. G.M. Hackbarth, chairman, Medicare Payment Advisory Commission, "Options to Improve Medicare's Payments to Physicians," Testimony Prepared for the House Ways and Means Subcommittee on Health, 10 May 2007, http://www.medpac.gov/documents/051007_Testimony_MedPAC_physician_payment.pdf (accessed 9 May 2008);
36. and E.S. Fisher et al., "Creating Accountable Care Organizations: The Extended Hospital Medical Staff," Health Affairs 26, no. 1 (2007): w44-w57 (published online 5 December 2006; 10.1377/hlthaff.26.1.w44).